Journal of Child and Adolescent Psychopharmacology

Edit Your Profile

Journal of Child and Adolescent Psychopharmacology Journal

publication venue for

Effects of Extended-Release Methylphenidate Treatment on Cognitive Task Performance in Children with Autism Spectrum Disorder and Attention-Deficit/Hyperactivity Disorder. 30:414-426. 2020
Changes in Sleep Problems Across Attention-Deficit/Hyperactivity Disorder Treatment: Findings from the Multimodal Treatment of Attention-Deficit/Hyperactivity Disorder Study. 28:690-698. 2018
Parent-Reported Improvements in Family Functioning in a Randomized Controlled Trial of Lisdexamfetamine for Treatment of Parental Attention-Deficit/Hyperactivity Disorder. 27:250-257. 2017
Atomoxetine-Related Change in Sluggish Cognitive Tempo Is Partially Independent of Change in Attention-Deficit/Hyperactivity Disorder Inattentive Symptoms. 27:38-42. 2017
Technological Considerations for the Delivery of Real-Time Child Telemental Healthcare. 26:192-197. 2016
The Case for Telemental Health for Improving the Accessibility and Quality of Children's Mental Health Services. 26:186-191. 2016
Using Synchronous Videoconferencing to Deliver Family-Based Mental Healthcare. 26:229-234. 2016
Correction to "The Effectiveness and Tolerability of Central Nervous System Stimulants in School-Age Children with Attention-Deficit/Hyperactivity Disorder and Disruptive Mood Dysregulation Disorder across Home and School". 2016
The Effectiveness and Tolerability of Central Nervous System Stimulants in School-Age Children with Attention-Deficit/Hyperactivity Disorder and Disruptive Mood Dysregulation Disorder Across Home and School. 26:154-163. 2016
A Pilot Study of Stimulant Medication for Adults with Attention-Deficit/Hyperactivity Disorder (ADHD) Who Are Parents of Adolescents with ADHD: The Acute Effects of Stimulant Medication on Observed Parent-Adolescent Interactions. 24:582-585. 2014
Concordance Between Parent and Physician Medication Histories for Children and Adolescents with Attention-Deficit/Hyperactivity Disorder. 24:269-274. 2014
A Comparison of Atomoxetine Administered as Once Versus Twice Daily Dosing on the School and Home Functioning of Children with Attention-Deficit/Hyperactivity Disorder. 21:21-32. 2011
Comparison of open-label, 8-week trials of olanzapine monotherapy and topiramate augmentation of olanzapine for the treatment of pediatric bipolar disorder. 19:539-545. 2009
Dopamine-Related Genotypes and the Dose-Response Effect of Methylphenidate on Eating in Attention-Deficit/Hyperactivity Disorder Youths. 19:127-136. 2009
The Efficacy and Tolerability of Methylphenidate and Behavior Modification in Children with Attention-Deficit/Hyperactivity Disorder and Severe Mood Dysregulation. 18:573-588. 2008
Unexpected effects of methylphenidate in attention-deficit/hyperactivity disorder reflect decreases in core/secondary symptoms and physical complaints common to all children. 18:237-247. 2008
Latino versus Caucasian response to atomoxetine in attention-deficit/hyperactivity disorder. 18:44-53. 2008
An open trial of adjunctive donepezil in attention-deficit/hyperactivity disorder. 15:947-955. 2005
Dexmethylphenidate Extended Release-Associated Orofacial Dyskinesia in an Adolescent with Autism Spectrum Disorder After Prolonged Use 2018
Pharmacotherapy of adolescent substance use disorders: A review of the literature 2005
Future Directions in the Use of Telemental Health to Improve the Accessibility and Quality of Children's Mental Health Services 2016

International Standard Serial Number (ISSN)

1044-5463

Electronic International Standard Serial Number (EISSN)

1557-8992